Literature DB >> 7565972

Epidemic optic neuropathy in Cuba--clinical characterization and risk factors.

.   

Abstract

BACKGROUND: From 1991 to 1993, epidemic optic and peripheral neuropathy affected more than 50,000 people in Cuba. The number of new cases decreased after the initiation of vitamin supplementation in the population. In September 1993, Cuban and U.S. investigators conducted a study to characterize and identify risk factors for the optic form of the syndrome.
METHODS: We conducted ophthalmologic and neurologic examinations, assessed exposure to potential toxins, administered a semiquantitative food-frequency questionnaire, and assessed serum measures of nutritional status in 123 patients with severe optic neuropathy, matched for sex and age to randomly chosen normal subjects.
RESULTS: In the case patients, prominent clinical features were subacute loss of visual acuity with field defects, diminished color vision, optic-nerve pallor, and decreased sensitivity to vibration and temperature in the legs. Tobacco use, particularly cigar smoking, was associated with an increased risk of optic neuropathy. The risk was reduced among subjects with higher dietary intakes of methionine, vitamin B12, riboflavin, and niacin and higher serum concentrations of antioxidant carotenoids. The risk was also reduced among subjects who raised chickens at home or had relatives living overseas--factors that may be indirect measures of increased food availability.
CONCLUSIONS: The epidemic of optic and peripheral neuropathy in Cuba between 1991 and 1993 appears to be linked to reduced nutrient intake caused by the country's deteriorating economic situation and the high prevalence of tobacco use.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565972     DOI: 10.1056/NEJM199511023331803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  Investigations of selected historically important syndromic outbreaks: impact and lessons learned for public health preparedness and response.

Authors:  Richard A Goodman; Joseph M Posid; Tanja Popovic
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

2.  Leber hereditary optic neuropathy: bad habits, bad vision?

Authors:  Nancy J Newman
Journal:  Brain       Date:  2009-09       Impact factor: 13.501

3.  Global health. Fifty years of U.S. embargo: Cuba's health outcomes and lessons.

Authors:  Paul K Drain; Michele Barry
Journal:  Science       Date:  2010-04-30       Impact factor: 47.728

Review 4.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 5.  Treatment and Outcomes in Nutritional Optic Neuropathy.

Authors:  Joanna M Jefferis; Simon J Hickman
Journal:  Curr Treat Options Neurol       Date:  2019-02-07       Impact factor: 3.598

6.  Smoking and disease progression in multiple sclerosis.

Authors:  Brian C Healy; Eman N Ali; Charles R G Guttmann; Tanuja Chitnis; Bonnie I Glanz; Guy Buckle; Maria Houtchens; Lynn Stazzone; Jennifer Moodie; Annika M Berger; Yang Duan; Rohit Bakshi; Samia Khoury; Howard Weiner; Alberto Ascherio
Journal:  Arch Neurol       Date:  2009-07

7.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 8.  Ocular manifestations of drug and alcohol abuse.

Authors:  Jason Peragallo; Valérie Biousse; Nancy J Newman
Journal:  Curr Opin Ophthalmol       Date:  2013-11       Impact factor: 3.761

9.  Cross-sectional dietary deficiencies among a prison population in Papua New Guinea.

Authors:  Camilla Gould; Benoit Tousignant; Garry Brian; Robert McKay; Rosalind Gibson; Karl Bailey; Bernard J Venn
Journal:  BMC Int Health Hum Rights       Date:  2013-04-22

Review 10.  Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.

Authors:  Cullen O'Gorman; Robyn Lucas; Bruce Taylor
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.